Background: Acute lymphoblastic leukemia (ALL) accounts for 80% of all leukemias diagnosed in children. Although ALL age patterns are consistent across racial/ethnic groups, their incidence and mortality rates are highly variable. We assessed the age-standardized ALL incidence and mortality rates of Puerto Rican Hispanic (PRH) children and compared them with those of US mainland Hispanics (USH), non-Hispanic Whites (NHW), non-Hispanic Blacks (NHB), and Non-Hispanic Asian or Pacific Islanders (NHAPI). Methods: Differences between racial/ethnic groups were assessed by estimating the standardized rate ratio (SRR) for 2010 to 2014. Secondary data analyses of the Puerto Rico Central Cancer Registry and the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) databases were performed for the 2001 to 2016 period. Results: PRH children had 31% lower incidence rates than USH, but 86% higher incidence rates than NHB. In addition, the incidence trends of ALL increased significantly from 2001 to 2016 among PRH and USH, with 5% and 0.9% per year, respectively. Moreover, PRH have a lower 5-year overall survival (81.7%) when compared with other racial/ethnic groups. Conclusions: PRH children were found to have disparities in ALL incidence and mortality rates compared with other racial/ethnic groups in the US. Additional research is warranted to identify the genetic and environmental risk factors that may be associated with the disparities observed. Impact: This is the first study reporting the incidence and mortality rates of childhood ALL for PRH and making comparisons with other racial/ethnic groups in the US. See related commentary by Mejía-Aranguré and Núñez-Enríquez, p. 999
Background: Major events, such as Hurricanes Irma and Maria and the coronavirus disease 2019 (COVID‐19) pandemic disrupted Puerto Rico's health system. Lack of access to colorectal cancer (CRC) screening services may have impeded timely diagnosis. The authors examined the impact of these events on CRC incidence in Puerto Rico.Methods: The Puerto Rico Central Cancer Registry database allowed the authors to obtain CRC cases from 2012 to 2021. An interrupted time‐series analysis was performed to examine changes in CRC incidence immediately after and during the periods after the hurricanes and the pandemic. Analysis periods included: pre‐hurricanes, post‐hurricanes, and post‐COVID‐19 lockdown restrictions.Results: We observed a level change of −8.3 CRC cases was observed in the month the hurricanes struck Puerto Rico, corresponding to an immediate decrease of 17.5%. After a slight upward trend, a second decline of 39.4 CRC cases was estimated after the COVID‐19 lockdown restrictions, representing an immediate change of −24.2%. By the end of the study, the estimated numbers of patients with early stage CRC patients and those aged 50–75 years did not reach the expected numbers. In addition, CRC cases in patients with late‐stage disease and in those aged younger than 50 years and aged 76 years and older exceeded the expected numbers.Conclusions: Hurricanes Irma and Maria and the COVID‐19 pandemic caused a decrease in CRC incidence in Puerto Rico. This analysis suggests that limited access to CRC screening services during these events likely hindered CRC diagnoses. To fully understand the long‐term effects, monitoring of CRC trends will be necessary in the coming years.
24 June 2022 in Clinical Lymphoma Myeloma and Leukemia
Background: Toxic environmental pollutants are a risk factor for some cancers. We conducted an ecological study to assess the cancer risk in Puerto Rico after 15 years of exposure. Methods: Cancer incidence data (2018–2022) were obtained from the Puerto Rico Central Cancer Registry. Contaminated areas were defined as municipalities with industrial facilities reporting on-site toxic chemical emissions to the Environmental Protection Agency's Toxic Release Inventory (TRI) from 2006 to 2020. We estimated cancer risk using the age-standardized incidence RR with 95% confidence intervals (95% CI) by cancer type and sex. This was repeated for the frequency of on-site TRI emissions (none, intermittent, and continuous). All analyses were performed using SEER*Stat v8.4.4. Results: Between 2018 and 2022, 80,179 invasive cancer cases were diagnosed in Puerto Rico. Residents of contaminated municipalities had a 7% higher risk of all cancer types (RR: 1.07; 95% CI, 1.05–1.09) than those in noncontaminated municipalities, similar to females (RR: 1.05; 95% CI, 1.02–1.07) and males (RR: 1.10; 95% CI, 1.07–1.12). Risk was higher in highly contaminated municipalities, with a 5% increase in females (RR = 1.05; 95% CI, 1.03–1.08) and 12% in males (RR = 1.12; 95% CI, 1.09–1.15). Conclusions: The data suggest higher cancer rates in municipalities with TRI facilities, emphasizing the need for research, environmental interventions, and public health actions to mitigate toxic chemical exposure in Puerto Rico. Impact: This study contributes additional knowledge of Puerto Rico’s cancer burden by identifying the relationship that may exist between living in municipalities with industries reporting the emission of toxic chemicals and cancer risk.
PURPOSE: Lung cancer remains one of the leading causes of cancer-related mortality worldwide. It is the third cause of death among patients with cancer in Puerto Rico (PR) and non–small cell lung cancer (NSCLC) is the most prevalent. This study aims to describe the first-line treatment (1LT) and health care resource utilization (HCRU) among patients with NSCLC in PR. METHODS: A retrospective cohort study was conducted using the PR Central Cancer Registry Health Insurance Linkage Database to describe patients with NSCLC from 2012 to 2016. It describes sociodemographic and clinical characteristics on the basis of stage and histology and includes 1LT patterns and HCRU. RESULTS: A total of 1,011 patients met the inclusion criteria. Most were male (57.1%), married (54.1%), and had no comorbidities (55.8%). A significant proportion of patients (71.1%) were diagnosed at stages III and IV, with nonsquamous cell carcinoma being the most prevalent histology group (75.9%). About 61.7% received systemic therapy, 36.7% received radiotherapy, and 21.9% underwent surgery. Platinum (Pt)-based combinations were the most common 1LT (82.9%). On average, patients had 4.7 emergency room visits, nearly six hospitalizations, and 22.4 outpatient visits annually. The mean frequencies of positron emission tomography, ultrasounds, computerized tomography scans, and magnetic resonance imaging were 0.95, 0.11, 4.88, and 0.91, respectively. CONCLUSION: To our knowledge, this study provides the first description of 1LT patterns, HCRU, and sociodemographic information among patients with NSCLC in PR. A significant number of patients were diagnosed at stage III or higher and received Pt-based systemic therapy as their 1LT. More research is required to investigate treatment patterns beyond the 1LT and to gain a comprehensive understanding of optimal care interventions and factors associated with early NSCLC diagnosis.
Colorectal cancer (CRC) is the leading cause of cancer-related death in Puerto Rico, a U.S. territory with noted disparities in CRC incidence, particularly among those with early-onset disease (EOCRC). Although EOCRC incidence has been consistently increasing in the U.S. mainland, and a disparate burden has been reported among Hispanics, EOCRC mortality and survival are yet to be assessed among Hispanics living in Puerto Rico (PRH). In this study, we analyzed EOCRC mortality and survival trends in PRH and compared these to those of other U.S. populations. Mortality data were obtained from the Puerto Rico Central Cancer Registry and the Surveillance, Epidemiology, and End Results (SEER) program. Descriptive characteristics and temporal trends were derived via SEER*Stat software (version 9.0.42) and Joinpoint regression models, respectively. Relative survival was estimated using the Actuarial method and the Ederer II approach. Overall, CRC mortality trends showed a decline, but an increase in EOCRC mortality among Hispanics. PRH exhibited the lowest 5-year survival in regional cancers (54.10%), with NHB having the lowest survival among younger individuals. This study highlights significant disparities in EOCRC mortality trends and underscores an urgent need for targeted public health strategies and research efforts to address the disproportionate burden of EOCRC among PRH.